DataView, a three-year-old teleradiology firm and nuclear medicineremanufacturer based in Tucker, GA, is attempting to build aninternational medical imaging reading and advisory service. The network will focus on China/U.S. communications, accordingto
DataView, a three-year-old teleradiology firm and nuclear medicineremanufacturer based in Tucker, GA, is attempting to build aninternational medical imaging reading and advisory service.
The network will focus on China/U.S. communications, accordingto president Kurt T. Farhy.
"We have negotiated a plan to go worldwide," Farhytold SCAN. "We have international backing, which providesus opportunity for sales to Asia and Europe. We are working witha Chinese delegation that will travel through many of the Asiancountries."
DataView is negotiating with a U.S. medical school to providethe clinical expertise for its imaging network. The company willoffer the university its picture archiving and communicationssystems technology on a fee-per-use basis, Farhy said.
DataView introduced its Image Transport 2 teleradiology systemin June. The unit has a noninterlaced monitor that can displaycolor as well as gray-scale medical images. It uses Intel's 25-MHz486 microprocessor.
China is ripe for this type of service because of its underdevelopedmedical care system and a brain drain of trained physicians leavingthe country, Farhy said.
The DataView network will center on Beijing, Singapore, Taiwanand Hong Kong. It will also stretch to Saudi Arabia, which willbecome a hub for servicing neighboring countries in the MiddleEast. All types of medical images and text will be handled throughsatellite and local phone-line transmissions, he said.
DataView's international connection comes through a principalinvestor, who is Chinese, he said. The investor has been activein the U.S. for over a decade and has a large health-care portfolio.
A substantial investment will be made in the company to supportthis international drive. DataView should grow to a net worthof about $150 million over the next year, Farhy said.
"We will become one of the largest (teleradiology) companiesin the next seven months," he said.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.